Peer D - Search Results

1

Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.

Breiner-Goldstein E, Evron Z, Frenkel M, Cohen K, Meiron KN, Peer D, Roichman Y, Flescher E, Fridman M. Breiner-Goldstein E, et al. Among authors: peer d. ACS Med Chem Lett. 2011 May 12;2(7):528-31. doi: 10.1021/ml2001104. eCollection 2011 Jul 14. ACS Med Chem Lett. 2011. PMID: 24900344 Free PMC article.

2

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.

Rivkin I, Cohen K, Koffler J, Melikhov D, Peer D, Margalit R. Rivkin I, et al. Among authors: peer d. Biomaterials. 2010 Sep;31(27):7106-14. doi: 10.1016/j.biomaterials.2010.05.067. Epub 2010 Jun 17. Biomaterials. 2010. PMID: 20619792

3

Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers.

Bachar G, Cohen K, Hod R, Feinmesser R, Mizrachi A, Shpitzer T, Katz O, Peer D. Bachar G, et al. Among authors: peer d. Biomaterials. 2011 Jul;32(21):4840-8. doi: 10.1016/j.biomaterials.2011.03.040. Epub 2011 Apr 11. Biomaterials. 2011. PMID: 21482433

4

Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.

Mizrahy S, Raz SR, Hasgaard M, Liu H, Soffer-Tsur N, Cohen K, Dvash R, Landsman-Milo D, Bremer MG, Moghimi SM, Peer D. Mizrahy S, et al. Among authors: peer d. J Control Release. 2011 Dec 10;156(2):231-8. doi: 10.1016/j.jconrel.2011.06.031. Epub 2011 Jul 2. J Control Release. 2011. PMID: 21745506

5

Modulation of drug resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted nanoparticle clusters.

Cohen K, Emmanuel R, Kisin-Finfer E, Shabat D, Peer D. Cohen K, et al. Among authors: peer d. ACS Nano. 2014 Mar 25;8(3):2183-95. doi: 10.1021/nn500205b. Epub 2014 Feb 6. ACS Nano. 2014. PMID: 24494862

6

Metastability in lipid based particles exhibits temporally deterministic and controllable behavior.

Jacoby G, Cohen K, Barkan K, Talmon Y, Peer D, Beck R. Jacoby G, et al. Among authors: peer d. Sci Rep. 2015 Mar 30;5:9481. doi: 10.1038/srep09481. Sci Rep. 2015. PMID: 25820650 Free PMC article.

7

Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen.

Argov M, Kashi R, Peer D, Margalit R. Argov M, et al. Among authors: peer d. Cancer Lett. 2009 Feb 8;274(1):118-25. doi: 10.1016/j.canlet.2008.09.005. Epub 2008 Oct 11. Cancer Lett. 2009. PMID: 18851896

8

Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells.

Landesman-Milo D, Goldsmith M, Leviatan Ben-Arye S, Witenberg B, Brown E, Leibovitch S, Azriel S, Tabak S, Morad V, Peer D. Landesman-Milo D, et al. Among authors: peer d. Cancer Lett. 2013 Jul 1;334(2):221-7. doi: 10.1016/j.canlet.2012.08.024. Epub 2012 Aug 27. Cancer Lett. 2013. PMID: 22935680

9

eIF3c: a potential therapeutic target for cancer.

Emmanuel R, Weinstein S, Landesman-Milo D, Peer D. Emmanuel R, et al. Among authors: peer d. Cancer Lett. 2013 Aug 9;336(1):158-66. doi: 10.1016/j.canlet.2013.04.026. Epub 2013 Apr 25. Cancer Lett. 2013. PMID: 23623922

10

Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine.

Drinberg V, Bitcover R, Rajchenbach W, Peer D. Drinberg V, et al. Among authors: peer d. Cancer Lett. 2014 Nov 28;354(2):290-8. doi: 10.1016/j.canlet.2014.08.026. Epub 2014 Aug 27. Cancer Lett. 2014. PMID: 25173796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters